Lung Therapeutics, Inc.

Overview

• IndustryPharmaceutical Preparations¹
• HeadquartersTX¹
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Corporate structure

Lung Therapeutics, Inc. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive Officer, DirectorBrian Windsor named Apr 4, 2022²
• Executive OfficerCharles C. Garner named Apr 4, 2022²
• DirectorAaron G.L. Fletcher named Apr 4, 2022²
• DirectorWilliam C. Fairey named Apr 4, 2022²

Filings

1 filings to the SEC since October 2021: 1 private raises. The latest 1:

1. Apr 4, 2022D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Lung Therapeutics, Inc. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• TFF Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023³

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Mar 14, 2022Raised $10.1 million in a private offering of equity² Form D: $15 million offered in all Form D

PPP loans

Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA⁴. Matched to this company by name and state.

1. Apr 14, 2020$250.4K PPP loan (first draw) from Ciera Bank⁴To LUNG THERAPEUTICS INC, Austin TX; $253.1K forgiven May 21, 2021